✦ LIBER ✦

Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter

✍ Scribed by Karl Strecker; Florian Wegner; Swen Hesse; Georg-Alexander Becker; Marianne Patt; Philipp M. Meyer; Donald Lobsien; Johannes Schwarz; Osama Sabri

Book ID: 106094974
Publisher: Springer
Year: 2010
Tongue: English
Weight: 880 KB
Volume: 258
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-010-5666-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain serotonin transporter binding in n

Brain serotonin transporter binding in non-depressed patients with Parkinson's disease

✍ M. Guttman; I. Boileau; J. Warsh; J. A. Saint-Cyr; N. Ginovart; T. McCluskey; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB

Striatal dopamine transporter binding in

Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation

✍ Ioannis U. Isaias; Riccardo Benti; Stefano Goldwurm; Michela Zini; Roberto Cilia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

We measured striatal dopamine transporter binding using [(123)I]ioflupane and SPECT in patients with Parkinson's disease associated with the LRRK2 (PARK8) Gly2019Ser gene mutation (LRRK2-PD) and in gene-negative patients with idiopathic Parkinson's disease (IPD) of comparable disease duration and se

Striatal dopamine transporter binding in

Striatal dopamine transporter binding in patients with Parkinson's disease and severe occupational hydrocarbon exposure

✍ M. Canesi; R. Benti; G. Marotta; R. Cilia; I. U. Isaias; P. Gerundini; G. Pezzol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

Association of a polymorphism in the dop

Association of a polymorphism in the dopamine-transporter gene with parkinson's disease

✍ Dr. David G. le Couteur; Peter W. Leighton; Sally J. McCann; Susan M. Pond 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

## Abstract The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins.

Periodic leg movements in patients with

Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding

✍ Svenja Happe; Walter Pirker; Gerhard Klösch; Cornelia Sauter; Josef Zeitlhofer 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 193 KB

Elevated serotonin transporter binding i

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB

✍ Isabelle Boileau; Jerry J. Warsh; Mark Guttman; Jean A. Saint-Cyr; Tina McCluske 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

## Abstract This study investigated whether abnormalities in serotonin transporter binding occur in Parkinson's disease (PD) patients with concurrent depression. We estimated serotonin transporter levels in seven clinically depressed early‐stage PD patients and in seven healthy matched‐control subj